By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Food and Drug Administration (FDA) 

5600 Fishers Lane

Rockville  Maryland  20857  U.S.A.
Phone: 888-463-6332 or 1-888-INFO-FDA (1-888-463-6332) Fax:

FDA Overview:

The Food and Drug Administration is one of the nation's oldest and most respected consumer protection agencies. This presentation will tell you about FDA's responsibilities, the tools we use to fulfill those responsibilities, and our priorities for improving the way we serve the public.

•Stated most simply, FDA's mission is:
- to promote and protect the public health by helping safe and effective products reach the market in a timely way,
- To monitor products for continued safety after they are in use, and
- To help the public get the accurate, science-based information needed to improve health.

FDA's Mission Statement

The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.

Key Statistics

Ownership: Private

Web Site: FDA


Company News
FDA Grants Fast Track Designation For Amicus (FOLD)’ Migalastat For Treatment Of Fabry Disease 9/19/2017 10:35:48 AM
Arkis Biosciences Achieves FDA Clearance of its CerebroFlo EVD Catheter with Endexo Technology 9/19/2017 9:51:50 AM
Teligent Announces FDA Approval Of Triamcinolone Acetonide Cream USP, 0.1% 9/19/2017 9:45:43 AM
Zivo Bioscience, Inc. And Nutriquest Conclude Two Poultry Studies With Positive Results, Continue To Move Forward With FDA Compliance 9/19/2017 9:41:56 AM
MiMedx Files With The FDA To Initiate The Company's Investigational New Drug Phase II Clinical Trial For Osteoarthritis Of The Knee 9/19/2017 8:43:51 AM
OptiNose Announces FDA Approval Of XHANCE (Fluticasone Propionate) Nasal Spray For The Treatment Of Nasal Polyps 9/19/2017 8:33:04 AM
Amylyx Receives FDA Orphan Drug Designation For AMX0035 For The Treatment Of Amyotrophic Lateral Sclerosis 9/19/2017 8:24:15 AM
Cycle Pharma Receives FDA Approval And Launches Ketorolac Tromethamine Injection 30mg/ml In The U.S. 9/19/2017 8:15:42 AM
FDA Approves Symbiomix’ Solosec (Secnidazole) Oral Granules For The Treatment Of Bacterial Vaginosis In Adult Women 9/19/2017 7:57:30 AM
ProQR Therapeutics (PRQR) Receives Orphan Drug Designation From FDA For Drug Candidate QR-313 For Dystrophic Epidermolysis Bullosa And Will Present Data At Two Scientific Conferences 9/19/2017 7:39:10 AM